At a glance
ClinicalIndex Comparison RecordN/ACompleted· 29 enrolled
Drug / intervention
Galvanic Vestibular Stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non-pharmaceutical Motion Sickness Mitigation
In Brief
A clinical study evaluating Galvanic Vestibular Stimulation for Healthy. Completed, enrolled 29 participants across 1 site.
Detailed Summary
The purpose of this study is evaluate the effect of timing and magnitude on the administration of our nonpharmaceutical treatment to motion sickness, and to evaluate the effect of Galvanic Vestibular Stimulation (GVR) amplitude on functional fitness task performance.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartMar 2021
First PostedApr 2021
Primary CompletionAug 2022
TodayJul 2026
First PostedApr 26, 2021
Enrollment StartMar 12, 2021
Primary CompletionAug 30, 2022
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 5.2 years ago
Interventions
Galvanic Vestibular Stimulationdevice
Low electrical currents to the vestibular system, to induce the realistic sensation of motion (i.e., the g-forces that occur during flight) as well as null out motion perception.